Antibiotics for the common cold and acute purulent rhinitis
- 20 July 2005
- reference entry
- Published by Wiley
- No. 3,p. CD000247
- https://doi.org/10.1002/14651858.cd000247.pub2
Abstract
Background It has long been believed that antibiotics have no role in the treatment of common colds yet they are often prescribed in the belief that they may prevent secondary bacterial infections. Objectives To determine: 1. the efficacy of antibiotics, in comparison to placebo; 2. if antibiotics have any influence on acute purulent rhinitis; and 3. the adverse outcomes for antibiotics in this condition. Search methods For this 2009 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 3), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (1966 to July 2009) and EMBASE (1980 to August 2009). Selection criteria Randomised controlled trials (RCTs) comparing any antibiotic therapy against placebo in people with symptoms of acute upper respiratory tract infections for less than seven days, or acute purulent rhinitis less than 10 days in duration. Data collection and analysis Both review authors independently assessed trial quality and extracted data. Main results Participants receiving antibiotics did no better in terms of lack of cure or persistence of symptoms than those on placebo (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.59 to 1.51, (random‐effects)), based on a pooled analysis of six trials with a total of 1047 participants. The RR of adverse effects in the antibiotic group was 1.8, 95% CI 1.01 to 3.21, (random‐effects). Adult participants had a significantly greater risk of adverse effects with antibiotics than with placebo (RR 2.62, 95% CI 1.32 to 5.18) (random‐effects) while there was no greater risk in children (RR 0.91, 95% CI 0.51 to 1.63). The pooled RR for persisting acute purulent rhinitis with antibiotics compared to placebo was 0.63 (95% CI 0.38 to 1.07) (random‐effects), based on five studies with 772 participants. There was an increase in adverse effects in the studies of antibiotic for acute purulent rhinitis (RR 1.46, 95% CI 1.10 to 1.94). Authors' conclusions There is insufficient evidence of benefit to warrant the use of antibiotics for upper respiratory tract infections in children or adults. Antibiotics cause significant adverse effects in adults when given for the common cold and in all ages when given for acute purulent rhinitis. The evidence on acute purulent rhinitis and acute clear rhinitis suggests no benefit for antibiotics for these conditions and their routine use is not recommended.Keywords
This publication has 43 references indexed in Scilit:
- Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Colour of respiratory discharge and antibiotic useThe Lancet, 1997
- Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretionsThe Lancet, 1996
- Potential interventions for preventing pneumonia among young childrenThe Pediatric Infectious Disease Journal, 1993
- Amoxycillin and co-trimoxazole in presumed viral respiratory infections of childhood: placebo-controlled trial.BMJ, 1977
- Randomised controlled trial of antibiotics in patients with cough and purulent sputum.BMJ, 1976
- Evaluation of orally administered antibiotics for treatment of upper respiratory infections in Thai childrenThe Journal of Pediatrics, 1971
- Medical Management of Purulent RhinitisClinical Pediatrics, 1966
- Antibiotics and chemotherapeutic agents in the treatment of uncomplicated respiratory infections in children: A controlled studyThe Journal of Pediatrics, 1956
- Prophylaxis of upper respiratory infections in children treated with oral penicillinThe Journal of Pediatrics, 1948